Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis

被引:11
|
作者
Magro, Fernando [1 ,2 ,3 ,4 ]
Estevinho, Maria Manuela [1 ,5 ]
Dias, Claudia Camila [6 ,7 ]
Correia, Luis [8 ]
Lago, Paula [9 ]
Ministro, Paula [10 ]
Portela, Francisco [11 ]
Feakins, Roger [12 ]
Danese, Silvio [13 ,14 ]
Peyrin-Biroulet, Laurent [15 ,16 ]
机构
[1] Univ Porto, Fac Med, Dept Biomed, Unit Pharmacol & Therapeut, Rua Placido Costa, P-4200450 Porto, Portugal
[2] Sao Joao Hosp Ctr, Dept Gastroenterol, Porto, Portugal
[3] Ctr Drug Discovery & Innovat Med, MedInUP, Porto, Portugal
[4] Sao Joao Hosp Univ Ctr, Clin Pharmacol Unit, Porto, Portugal
[5] Vila Nova Gaia Espinho Hosp Ctr, Dept Gastroenterol, Vila Nova De Gaia, Portugal
[6] Univ Porto, Dept Community Med Informat & Decis Hlth, Fac Med, Porto, Portugal
[7] Ctr Hlth Technol & Serv Res, Porto, Portugal
[8] Univ Lisbon, Santa Maria Hosp, Dept Gastroenterol & Hepatol, Lisbon, Portugal
[9] Porto Hosp Ctr, Dept Gastroenterol, Porto, Portugal
[10] Tondela Viseu Hosp Ctr, Dept Gastroenterol, Viseu, Portugal
[11] Univ Hosp Ctr Coimbra, Dept Gastroenterol, Coimbra, Portugal
[12] Royal Free London NHS Fdn Trust, Dept Histopathol, London, England
[13] Humanitas Clin & Res Ctr IRCCS, IBD Ctr, Dept Gastroenterol, Milan, Italy
[14] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[15] Lorraine Univ, Nancy Univ Hosp, Inst Natl Sante & Rech Med U954, Nancy, Meurthe Moselle, France
[16] Lorraine Univ, Nancy Univ Hosp, Dept Gastroenterol, Nancy, France
来源
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷 / 04期
关键词
Histology; inflammatory bowel disease; treatment outcomes; ulcerative colitis; RELAPSE; REMISSION; THERAPY; MARKERS;
D O I
10.1093/ecco-jcc/jjaa176
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Interest in histology for ulcerative colitis [UC] has increased recently. This systematic review and meta-analysis aims to assess, for the first time, whether histological outcomes are more informative than endoscopic and clinical outcomes in distinguishing the impact of intervention over placebo in induction trials. Methods: MEDLINE, ScienceDirect and Cochrane Central Register of Controlled Trials were searched to identify randomized placebo-controlled trials [RCTs] enrolling moderate-to-severe UC patients. Studies were assessed using the Quality Assessment Tool for Studies with Diverse Designs. We analysed the pooled proportion of patients achieving clinical, endoscopic and histological remission and response after a pharmacological intervention and compared the results with those of placebo-treated patients by using a random-effects model. Results: From 889 identified records, 13 RCTs were included. The odds ratio [OR] for remission was higher in patients receiving intervention than in those under placebo for clinical (OR 2.13, 95% confidence interval [CI] 1.33-3.43), endoscopic [OR 1.46, 95% CI 0.19-11.18] and histological remission [OR 1.85, 95% CI 1.20-2.84]. Significant differences were observed for all response outcomes [clinical: OR 2.27, 95% CI 1.84-2.85; endoscopic: OR 2.16, 95% CI 1.51-3.10; histological: OR 3.63, 95% CI, 1.41-9.36]. No significant heterogeneity existed; no subgroup effects were found for duration of the induction or histological scale [p>0.05]. Clinical and histological remission and endoscopic response were concordant in discriminating interventions from placebo. Conclusion: Histological outcomes are informative in trials of moderate-to-severe UC. Further studies analysing histology at the end of induction are needed to confirm its relevance in distinguishing the efficacy of an intervention over placebo in comparison to clinical and endoscopic outcomes and to explore its prognostic value.
引用
收藏
页码:551 / 566
页数:16
相关论文
共 50 条
  • [1] Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis (vol 15, pg 551, 2021)
    Vermeire, Severine
    Lukas, Milan
    Magro, Fernando
    Adsul, Shashi
    Lindner, Dirk
    Rosario, Maria
    Roth, Jeannine
    Danese, Silvio
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 (04): : 696 - 696
  • [2] Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis
    Trigo-Vicente, Cristina
    Gimeno-Ballester, Vicente
    Garcia-Lopez, Santiago
    Lopez-Del Val, Alejandro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (06) : 1411 - 1419
  • [3] Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis
    Cristina Trigo-Vicente
    Vicente Gimeno-Ballester
    Santiago García-López
    Alejandro López-Del Val
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 1411 - 1419
  • [4] Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis
    Sedano, Rocio
    Hogan, Malcolm
    Nguyen, Tran M.
    Chang, Joshua
    Zou, G. Y.
    Macdonald, John K.
    Vande Casteele, Niels
    Hanzel, Jurij
    Crowley, Eileen
    Battat, Robert
    Dulai, Parambir S.
    Singh, Siddharth
    D'Haens, Geert
    Sandborn, William
    Feagan, Brian G.
    Ma, Christopher
    Jairath, Vipul
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 (02): : 224 - 243
  • [5] Induction of endoscopic response: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis
    Vickers, A.
    Nag, A.
    Devine, B.
    Sands, B. E.
    Panaccione, R.
    Peyrin-Biroulet, L.
    Danese, S.
    Vermeire, S.
    Gorelick, K. J.
    Goetsch, M.
    Hartley, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S410 - S411
  • [6] SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF ENDOSCOPIC IMPROVEMENT FOR TREATMENT OF MODERATE-SEVERE ULCERATIVE COLITIS
    Aggarwal, S.
    Kumar, S.
    Bela, A.
    Topaloglu, O.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S26 - S26
  • [7] Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis
    Bonovas, S.
    Lytras, T.
    Nikolopoulos, G.
    Peyrin-Biroulet, L.
    Danese, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (04) : 454 - 465
  • [8] Efficacy and safety of hyperbaric oxygen therapy for moderate-to-severe ulcerative colitis: a protocol for a systematic review and meta-analysis
    Luo, Lihong
    Qing, Lei
    Yao, Chengjiao
    Liu, Dongying
    Li, Yilin
    Li, Tinglin
    Feng, Peimin
    [J]. BMJ OPEN, 2021, 11 (06):
  • [9] Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
    Attauabi, Mohamed
    Dahl, Emilie Kristine
    Burisch, Johan
    Gubatan, John
    Nielsen, Ole Haagen
    Seidelin, Jakob Benedict
    [J]. ECLINICALMEDICINE, 2023, 57
  • [10] Systematic Review with Meta-analysis: Efficacy and Safety of Upadacitinib in Managing Moderate-to-Severe Crohn's Disease and Ulcerative Colitis
    Niu, Chengu
    Zhang, Jing
    Napel, Mahesh
    Boppana, Leela Krishna Teja
    Anas, Hashem
    Jadhav, Nagesh
    Dunnigan, Karin
    Okolo, Patrick I.
    [J]. CLINICAL DRUG INVESTIGATION, 2024, 44 (06) : 371 - 385